Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH)Innovative drugs Avimeplanib and Golirelin included in the new version of the national medical insurance directory.
Ailis (688578.SH) announced that its innovative drug Fufelnib hydrochloride tablets (trade name "Yevshah, hereinafter referred to as "Fufelnib") and Goriracetam citrate tablets (trade name "Airikae, hereinafter referred to as "Goriracetam") have been included in the "National Basic Medical Insurance, Maternity Insurance, and Work-related Injury Insurance Drug List (2025)" (hereinafter referred to as the "National Medical Insurance List"). Among them, the first-line and second-line indications for Fufelnib continue to be included in the National Medical Insurance List after negotiations with medical insurance; the second-line indication for Goriracetam is included in the National Medical Insurance List for the first time through negotiations with medical insurance.
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH) announced that their innovative drugs Fumeitinib Mesylate (trade name "Evisza", hereinafter referred to as "Fumeitinib") and Golailese Citrate (trade name "Erikai", hereinafter referred to as "Golailese") have been included in the "National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug List (2025)" (hereinafter referred to as "National Medical Insurance List"). Among them, Fumeitinib's first-line and second-line indications have been continued to be included in the National Medical Insurance List after medical insurance negotiations; Golailese's second-line indications have been included in the National Medical Insurance List for the first time through medical insurance negotiations.
Related Articles
Industrial Market Strategy for 2026: Fierce Competition, Comprehensive Bull Market Sets Sail
Original YuanChuang Group (001325.SZ) IPO price set at 24.75 yuan per share, subscription to start on December 9th.
Improved YuanChuang Group (001325.SZ) sets IPO price at 24.75 yuan per share, subscription to begin on December 9th.
China National Chemical Engineering (601117.SH): Nylon new material project reaches production.
Industrial Market Strategy for 2026: Fierce Competition, Comprehensive Bull Market Sets Sail
Original YuanChuang Group (001325.SZ) IPO price set at 24.75 yuan per share, subscription to start on December 9th.
Improved YuanChuang Group (001325.SZ) sets IPO price at 24.75 yuan per share, subscription to begin on December 9th.
China National Chemical Engineering (601117.SH): Nylon new material project reaches production.
